A Comparative Study of RMI and ROMA in Women Presenting with an Adnexal Mass

A Comparative Study of RMI and ROMA in Women Presenting with an Adnexal Mass Objective Differentiation between benign and malignant ovarian neoplasms is essential to create a system for patient referrals. Therefore, tumor markers such as CA-125 and human epididymis protein 4 (HE-4) as well as the risk ovarian malignancy algorithm (ROMA) and risk malignancy index (RMI) values were considered individually and in combination to evaluate their utility in referral of women at a high risk of having an ovarian malignancy to cancer centers where multidisciplinary input is available. Methods Patients who were diagnosed with an adnexal mass through imaging analyses or clinically (n = 35) were assessed for their expression of the tumor markers CA-125 and HE-4 and were finally compared to the histopathology of the tumor after surgery which has been taken as the gold standard. The ROMA and RMI values were also determined. The sensitivity, specificity, PPV, NPV, PLR and NLR of each parameter were calculated. Two different sets of analysis were made: one including benign and borderline masses together and the other including malignant and borderline masses together. Results The sensitivity of ROMA (91%) was highest when compared to RMI, CA-125 and HE-4. Specificity and positive likelihood ratio of HE-4 were highest at 87.5% and 5.1, respectively, when compared http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Indian Journal of Gynecologic Oncology Springer Journals

A Comparative Study of RMI and ROMA in Women Presenting with an Adnexal Mass

Loading next page...
 
/lp/springer_journal/a-comparative-study-of-rmi-and-roma-in-women-presenting-with-an-Gbx2fsJmEt
Publisher
Springer Journals
Copyright
Copyright © 2017 by Association of Gynecologic Oncologists of India
Subject
Medicine & Public Health; Oncology; Surgical Oncology
ISSN
2363-8397
eISSN
2363-8400
D.O.I.
10.1007/s40944-017-0168-3
Publisher site
See Article on Publisher Site

Abstract

Objective Differentiation between benign and malignant ovarian neoplasms is essential to create a system for patient referrals. Therefore, tumor markers such as CA-125 and human epididymis protein 4 (HE-4) as well as the risk ovarian malignancy algorithm (ROMA) and risk malignancy index (RMI) values were considered individually and in combination to evaluate their utility in referral of women at a high risk of having an ovarian malignancy to cancer centers where multidisciplinary input is available. Methods Patients who were diagnosed with an adnexal mass through imaging analyses or clinically (n = 35) were assessed for their expression of the tumor markers CA-125 and HE-4 and were finally compared to the histopathology of the tumor after surgery which has been taken as the gold standard. The ROMA and RMI values were also determined. The sensitivity, specificity, PPV, NPV, PLR and NLR of each parameter were calculated. Two different sets of analysis were made: one including benign and borderline masses together and the other including malignant and borderline masses together. Results The sensitivity of ROMA (91%) was highest when compared to RMI, CA-125 and HE-4. Specificity and positive likelihood ratio of HE-4 were highest at 87.5% and 5.1, respectively, when compared

Journal

Indian Journal of Gynecologic OncologySpringer Journals

Published: Dec 30, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off